Aberrant CXCR4 signaling has been linked to more aggressive presentation in B cell lymphomas, yet no previous in vivo data existed. Here, we crossbred a murine model of hyperactive CXCR4 signaling (CXCR4C1013G) to established models of B cell lymphoma (Eµ-Myc / Eµ-TCL1) and identified CXCR4 as a crucial activator of multiple key oncogenic pathways. Furthermore, CXCR4 hyperactivation cooperatively accelerates tumorigenesis, promotes migration, and induces a more extranodal phenotype in Eµ-TCL1 driven lymphoma.
«
Aberrant CXCR4 signaling has been linked to more aggressive presentation in B cell lymphomas, yet no previous in vivo data existed. Here, we crossbred a murine model of hyperactive CXCR4 signaling (CXCR4C1013G) to established models of B cell lymphoma (Eµ-Myc / Eµ-TCL1) and identified CXCR4 as a crucial activator of multiple key oncogenic pathways. Furthermore, CXCR4 hyperactivation cooperatively accelerates tumorigenesis, promotes migration, and induces a more extranodal phenotype in Eµ-TCL1 dr...
»